Our 2026 Annual pledge supports research in Geriatric Cancer
Dr. Melissa Loh winner of the 2026 Team Science Award
Thank you to our anonymous donor for trusting and supporting our journey. We are forever grateful!
We recently received a substantial anonymous donation from a generous individual to support EGCRF's cancer research efforts. We gave this incredibly generous gift to the Wilmot Cancer Institute, and they were able to use it toward their internal grant awards. We have learned that these funds were awarded to Dr. Allison Magnusen for pilot studies in Geriatric Cancer. Dr. Magnusen, part of Wilmot’s Institute on Aging, is working on a National Institute on Aging (NIA) application.
Representatives from Wilmot have noted that, “…securing this accreditation will establish Wilmot as a leader in Aging and Oncology. The donation from the Edelman-Gardner Foundation will help fund the grant application process, including the development of pilot studies that demonstrate Wilmot's infrastructure for researching how cancer affects older populations. If successful, this NIA grant will expand funding opportunities, ensure five years of support, and enhance understanding of options for addressing ‘chemo-brain.’ It will help develop pilot studies that demonstrate Wilmot’s research capacity in this field. If awarded, the NIA grant will elevate Wilmot by opening more funding avenues, providing long-term support, and advancing research on managing ‘chemo-brain.’”
This is a truly wonderful example of how our donors make a difference in the fight against cancer.
Thank you!
To our Supporters,
The impact of cancer on our families, friends, and neighbors fuels our Foundation's mission to raise funds for research. Each story of patients and survivors motivates us for better treatments and hope for a cure. We are grateful for supporters' efforts in this cause. Looking ahead, promising research offers hope, even as we acknowledge the challenges faced by those fighting cancer and remembering those lost. With community support, progress continues, and we stand with everyone affected. No one is alone, and those we've lost will be remembered.
Research Update
Spring 2023
In 2023 our annual $50,000 donation was awarded to Pilot funding through the Wilmot Cancer Institute Team Science Pilot Award Program, for the project entitled “The Development of Extracellular Vesicles as a Biomarker for Antitumor Immune Responses.” The researchers associated with this project are: James McGrath and Scott Gerber.
In Layman’s terms: Pancreatic cancer is a devastating disease often diagnosed at an advanced stage. WCI’s research team has figured out how detect small particles unique to pancreatic tumor cells, enabling the potential to identify pancreatic cancer in its early stages, when it’s more amenable to treatment. This detection technology can also be used to monitor the effectiveness of treatment against the cancer. This breakthrough could significantly improve early detection and monitoring of pancreatic cancer, leading to better patient outcomes.
